Diagnos Laboratorium Utama Tbk. vs Bahtera Bumi Raya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Bahtera Bumi Raya Tbk. trades at Rp685 (market cap 541.18B, 25.2K 24h volume). The key difference: Bahtera Bumi Raya Tbk. is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 25.2K). Which is the better fit depends on your goals.
| DGNS | PGJO | |
|---|---|---|
Market Cap | 310.75B | 541.18B |
Volume | 963.6K | 25.2K |
Lot | 9.64K | 252 |
Turnover | 217.67M | 17.3M |
Average Price | 225.89 | 686.67 |
Value | 217.67M | 17.3M |
Indicative Equilibrium Price | 226 | 685 |
Indicative Equilibrium Volume | 1K | 68 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Tourindo Guide Indonesia Tbk (the Company) was established based on Notarial Deed No. 22 dated February 20, 2017 of Argo Wahyu Jati, S.H., M.Kn., a public notary in Tangerang Selatan. The Company started its commercial operations in 2018.
Read more on PGJO →